Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11788263.9Aexternal-prioritypatent/EP2638033B1/en
Application filed by Eli Lilly And CompanyfiledCriticalEli Lilly And Company
Publication of CY1116362T1publicationCriticalpatent/CY1116362T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Η παρούσα εφεύρεση παρέχει μία ένωση αμινοπυραζόλης, ή ένα φαρμακευτικά αποδεκτό άλας αυτής που αναστέλλει την Chk1 και χρησιμεύει στην αγωγή έναντι του καρκίνου.The present invention provides an aminopyrazole compound, or a pharmaceutically acceptable salt thereof, which inhibits Chk1 and is useful in the treatment of cancer.
CY20151100496T2010-11-082015-06-04
UNIONS USEFUL IN CHK1 SUSPENSION
CY1116362T1
(en)